Abstract
This study assessed associations of the use of statins for primary prevention with cardiovascular outcomes among adults ages ≥70 years. In a retrospective population-based cohort study, new users of statins without cardiovascular disease or diabetes mellitus were stratified by ages ≥70 years and <70 years. Using a time-dependent approach, adherence to statins was evaluated according to the proportion of days covered: <25%, 25%-50%, 50%-75%, and ≥75%. We assessed associations of statin therapy with increased risk of new-onset diabetes mellitus and with decreased risks of major adverse cardiovascular events and all-cause mortality. Of 42,767 new users of statins, 5970 (14%) were ages ≥70 years. The incident rates of major adverse cardiovascular events, all-cause mortality, and new-onset diabetes mellitus in the highest to lowest proportion of days covered categories were 16.9%, 16.7%, and 9.4% and 6.3%, 1.7%, and 9.4%, respectively. For the older group, the adjusted hazard ratios of major adverse cardiovascular events and mortality were significantly decreased for the highest adherence group (proportion of days covered ≥75%): 0.71 (0.57-0.88) and 0.68 (0.54-0.84), respectively. The respective hazard ratios were less favorable for...Continue Reading
References
Oct 31, 2003·American Journal of Epidemiology·Wayne A Ray
Jan 5, 2008·Journal of the American College of Cardiology·Jonathan AfilaloMark J Eisenberg
Feb 20, 2010·Lancet·Naveed SattarIan Ford
Jan 29, 2013·The American Journal of Cardiology·Eliano Pio NavareseJacek Kubica
Sep 13, 2013·The Cochrane Database of Systematic Reviews·Rod S TaylorShah Ebrahim
Nov 19, 2013·Journal of the American College of Cardiology·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
May 29, 2014·Current Opinion in Cardiology·Sophia ZoungasJohn McNeil
Nov 18, 2014·Population Health Metrics·Tomas KarpatiRan D Balicer
Apr 22, 2015·Annals of Internal Medicine·Michelle C OddenKirsten Bibbins-Domingo
Apr 16, 2016·Journal of the American College of Cardiology·Michael W RichUNKNOWN American College of Cardiology; and American Geriatrics Society
May 26, 2016·European Heart Journal·Massimo F PiepoliUNKNOWN ESC Scientific Document Group
Jun 18, 2016·Clinical Epidemiology·Aidan G O'KeeffeIrene Petersen
Sep 13, 2016·Lancet·Rory CollinsRichard Peto
Oct 30, 2016·The Canadian Journal of Cardiology·Todd J AndersonRichard Ward
Nov 14, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceMichael P Pignone
Feb 1, 2017·Drugs & Aging·Mark JonesAnnette Dobson
Jan 6, 2018·Journal of the American College of Cardiology·Martin Bødtker Mortensen, Erling Falk
Jul 11, 2018·Drugs & Aging·Wade ThompsonDorte Ejg Jarbøl
Sep 7, 2018·BMJ : British Medical Journal·Rafel RamosMaria Garcia-Gil
Jan 21, 2019·The American Journal of Medicine·Julien BezinAntoine Pariente
Jan 27, 2019·British Journal of Clinical Pharmacology·Rikje RuiterRobert Rissmann
Feb 5, 2019·Lancet·UNKNOWN Cholesterol Treatment Trialists' Collaboration
Feb 18, 2019·Atherosclerosis·Ji Eun JunYou-Cheol Hwang
Mar 15, 2019·Atherosclerosis·Kyu KimSang-Hak Lee
Mar 25, 2019·The Journal of Clinical Endocrinology and Metabolism·Oscar J PonceMohammad Hassan Murad
Sep 11, 2019·European Heart Journal·François MachUNKNOWN ESC Scientific Document Group